Villy Valcheva
Chief Tech/Sci/R&D Officer bij GH RESEARCH PLC
Profiel
Velichka Valcheva is currently working as the Chief Medical Officer at GH Research Plc.
Previously, she worked as the VP & Head-International Medical Affairs at Albireo Pharma, Inc. She holds a doctorate degree from the Medical University of Plovdiv and a graduate degree from Trinity College Dublin.
Actieve functies van Villy Valcheva
| Bedrijven | Functie | Begin |
|---|---|---|
| GH RESEARCH PLC | Chief Tech/Sci/R&D Officer | - |
Eerdere bekende functies van Villy Valcheva
| Bedrijven | Functie | Einde |
|---|---|---|
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | - |
Opleiding van Villy Valcheva
| Trinity College Dublin | Graduate Degree |
| Medical University of Plovdiv | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GH RESEARCH PLC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
